VIATRIS INC. for VIATRIS INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3 - Lower Drug Costs Now Act; Drug pricing issues, access to generic medicines, Medicare Part D program and generic drugs H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; Generic drug quality and FDA oversight H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022 Biosimilar interchangeability Part D Formulary Design and Generic Drug Tiering; Electronic labeling of prescription drugs H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; FDA facility inspections S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; Complex Generic Drug Approvals
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
| ANNE WILSON | — |
Copyright/Patent/Trademark CPT
Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements S4417 - Patent Trial and Appeal Board (PTAB) Reform Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
| ANNE WILSON | — |
Trade (domestic/foreign) TRD
Trade issues related to generic medicines Pharmaceutical supply chain
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
Financial Institutions/Investments/Securities FIN
Policy related to corporate governance
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID MARIN | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
Veterans VET
VA Access to affordable medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILL DENT | — |
| KATHARINE HAYES | — |
| DAVID MARIN | — |
| PETER WALLACE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.